Research Article
Other versions:
- ContentsContents
- Article InfoArticle Info
- CiteCite
- MetricsMetrics
- CommentComment
- RelatedRelated
- FigsFigs
- RefsRefs
- CitedCited
-
Article title
-
Abstract
-
Keywords
-
Introduction
-
Materials and methods
-
The involvement of inflammation in the progression of lung cancer
-
-
Markers of systemic Inflammation – the role of complete blood count parameters to inflammatory processes
-
Role of neutrophil-to-lymphocyte ratio (NLR) as a predictive and prognostic factor
-
New indices and scores for systemic inflammation, such as prognostic biomarkers in immunological treatment of advanced and metastatic NSCLC Systemic immune inflammation index (SII)
-
Advanced lung cancer inflammation index (ALI)
-
Khorana score (KS)
-
Other prognostic markers and their role in the management of patients with metastatic NSCLC
-
Conclusion
-
References
Subscribe to email alerts for current Article's categories